• US approves Janssen’s HIV pill Symtuza pharmatimes
    July 19, 2018
    Janssen’s Symtuza has been approved US regulators as the first and only complete, darunavir-based single-tablet regimen for the treatment of HIV in adults.
PharmaSources Customer Service